rosiglitazone has been researched along with transforming growth factor beta in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (47.06) | 29.6817 |
| 2010's | 16 (47.06) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Seuwen, K; Sottile, V | 2 |
| Brockman, JA; DuBois, RN; Gupta, RA; Raftery, LA; Sarraf, P; Shappell, SB; Willson, TM | 1 |
| Bierhaus, A; Brodbeck, K; Häring, HU; Schleicher, ED; Weigert, C | 1 |
| Burgess, HA; Daugherty, LE; Lakatos, HF; Phipps, RP; Ray, DM; Redonnet, M; Sime, PJ; Thatcher, TH | 1 |
| Ahn, KO; Choi, YH; Chung, BH; Ito, S; Kim, J; Li, C; Lim, SW; Sugawara, A; Sun, BK; Yang, CW; Yang, JH; Yoon, KH | 1 |
| Gu, Y; Lin, Q; Lin, SY; Ma, J | 1 |
| Averbukh, Z; Berman, S; Efrati, S; Feldman, L; Rapoport, M; Weissgarten, J | 1 |
| Chen, K; Ding, H; Jiang, H; Luo, H; Shen, X; Sun, T; Ye, F | 1 |
| Anderson, RG; Auwerx, J; Boucher, P; Herz, J; Li, WP; Matz, RL; Takayama, Y | 1 |
| Fu, WM; Lin, CP; Lin, TH; Tang, CH; Yang, RS | 1 |
| den Ouden, K; Goldschmeding, R; Joles, JA; Nguyen, TQ; Verhaar, MC; Westerweel, PE | 1 |
| Alastalo, TP; Alvira, CM; Bekker, JM; de Jesus Perez, VA; Guignabert, C; Hansmann, G; Morrell, NW; Rabinovitch, M; Schellong, S; Urashima, T; Wang, L | 1 |
| Averbukh, Z; Berman, S; Chachashvili, A; Cohen, N; Efrati, S; Siman-Tov, Y; Weissgarten, J | 1 |
| Ferguson, HE; Garcia-Bates, TM; Huxlin, KR; Kulkarni, A; Lehmann, GM; Phipps, RP; Sime, PJ; Thatcher, TH | 1 |
| Ambalavanan, N; Dasgupta, C; Guo, P; Rehan, VK; Sakurai, R; Torday, JS; Wang, Y | 1 |
| Garl, PJ; Han, G; Li, AG; Salter, K; Wang, XJ; Williams, CA | 1 |
| Nakachi, Y; Ninomiya, Y; Nishiyama, M; Okazaki, Y; Sugahara-Yamashita, Y; Tokuzawa, Y | 1 |
| Chan, LY; Guo, H; Lai, KN; Leung, JC; Tang, SC | 1 |
| Chan, LY; Cheng, AS; Lai, KN; Lan, HY; Leung, JC; Lin, M; Tang, SC | 1 |
| Dai, SS; Fu, XH; He, FT; Li, GB; Li, J; Wu, GZ; Zeng, YJ; Zhong, D | 1 |
| Feldon, SE; Guo, N; Phipps, RP; Woeller, CF | 1 |
| Ambalavanan, N; Bulger, A; Chen, YF; Halloran, B; James, ML; Nicola, T; Olave, N; Oparil, S; Rehan, V; Zhang, W | 1 |
| Clifton, K; Khosla, S; Kumar, A; Oursler, MJ; Ruan, M; Syed, F | 1 |
| Chen, J; Cui, R; Guo, L; Huang, MQ; Li, HM; Miao, ZL; Qin, WB; Wang, YX; Wang, ZN; Wei, XC; Yang, N | 1 |
| Hao, X; Li, W; Ren, X; Wang, P; Yin, Q; Yu, J | 1 |
| Bühren, J; Ciufo, D; DeMagistris, M; Hindman, HB; Huxlin, KR; Jeon, KI; MacRae, S; Phipps, RP; Sime, PJ | 1 |
| Bosshardt, DD; Buser, D; Gemperli, AC; Gruber, R; Miron, RJ; Sculean, A | 1 |
| Arkell, AM; Beaudoin, MS; Holloway, GP; Simpson, JA; Snook, LA; Stefanson, A; Wan, Z; Wright, DC | 1 |
| Li, M; Li, R; Li, Y; Liang, X; Shen, Y; Su, D; Xu, W | 1 |
| Bantug, G; Christofori, G; Diepenbruck, M; Hess, C; Ishay-Ronen, D; Ivanek, R; Kalathur, RKR; Morini, MF; Sugiyama, N; Tiede, S; Wang, J | 1 |
| Deng, J; Shao, M; Shao, X; Wang, X; Xia, Y; Xiong, C; Zhou, Q; Zou, H | 1 |
| Jacobs, C; Kumari, M; Lyubetskaya, A; Roh, HC; Rosen, ED; Taleb, S; Tenen, D; Tsai, LT | 1 |
| Feng, J; Gao, X; Li, J; Li, W; Li, Z; Lu, M; Meng, P; Zhang, Y | 1 |
1 review(s) available for rosiglitazone and transforming growth factor beta
| Article | Year |
|---|---|
A role for TGFbeta signaling in the pathogenesis of psoriasis.
Topics: Animals; Epidermis; Humans; Immune System; Inflammation; Keratinocytes; Mice; Mice, Transgenic; Psoriasis; Rosiglitazone; Signal Transduction; Skin; Skin Physiological Phenomena; Thiazolidinediones; Transforming Growth Factor beta; Transgenes | 2010 |
33 other study(ies) available for rosiglitazone and transforming growth factor beta
| Article | Year |
|---|---|
Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone).
Topics: Adipocytes; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Cell Line; Drug Synergism; Hypoglycemic Agents; Mesoderm; Mice; Rats; Rosiglitazone; Thiazoles; Thiazolidinediones; Transforming Growth Factor beta | 2000 |
A high-capacity screen for adipogenic differentiation.
Topics: Adipocytes; Cell Differentiation; Cells, Cultured; Glyceraldehyde-3-Phosphate Dehydrogenases; Hypoglycemic Agents; NAD; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Spectrophotometry, Ultraviolet; Thiazoles; Thiazolidinediones; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta3 | 2001 |
Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Division; Cell Line; COS Cells; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Epithelial Cells; Genes, Dominant; Genetic Vectors; Humans; In Situ Hybridization; Intermediate Filament Proteins; Intestines; Keratin-20; Ligands; Mutation; Oligonucleotide Array Sequence Analysis; Precipitin Tests; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Transforming Growth Factor beta | 2003 |
c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones.
Topics: Animals; Cells, Cultured; Chromans; Glucose; Hydrogen Peroxide; Mice; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Swine; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Troglitazone | 2003 |
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Topics: Actins; Anilides; Cell Differentiation; Collagen Type I; Fibroblasts; Humans; Hypoglycemic Agents; Lung; Muscle, Smooth; PPAR gamma; Prostaglandin D2; Pulmonary Fibrosis; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2005 |
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.
Topics: Angiotensin II; Animals; Apoptosis; Cyclosporine; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Islets of Langerhans; Kidney; Osteopontin; Pancreatic Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sialoglycoproteins; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
[Protection of rosiglitazone against renal interstitial lesion and its mechanism].
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Hypoglycemic Agents; Male; Nephritis, Interstitial; Nephrosclerosis; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta; Ureteral Obstruction | 2005 |
Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Diabetes Mellitus; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Mesangium; In Situ Nick-End Labeling; PPAR gamma; Pregnancy; Pregnancy, Animal; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Risk Factors; Rosiglitazone; Sensitivity and Specificity; Statistics, Nonparametric; Streptozocin; Thiazolidinediones; Transforming Growth Factor beta | 2006 |
Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
Topics: Anilides; Animals; Biological Transport; Blotting, Western; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Green Fluorescent Proteins; Microscopy, Fluorescence; Models, Biological; PPAR gamma; Prostaglandin D2; Recombinant Fusion Proteins; Rosiglitazone; Signal Transduction; Smad2 Protein; Thiazolidinediones; Transfection; Transforming Growth Factor beta | 2006 |
LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome.
Topics: Animals; Atherosclerosis; Blotting, Western; Low Density Lipoprotein Receptor-Related Protein-1; Marfan Syndrome; Mice; Mice, Transgenic; Microscopy, Fluorescence; Platelet-Derived Growth Factor; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Tunica Intima | 2007 |
PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
Topics: Aging; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Down-Regulation; Gene Expression Regulation, Enzymologic; Ligands; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoblasts; Osteogenesis; PPAR gamma; Prostaglandin D2; Rats; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Transforming Growth Factor beta | 2007 |
Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing.
Topics: Aneurysm; Animals; Blood Pressure; Bone Marrow Transplantation; Cell Movement; Disease Models, Animal; Endothelial Cells; Extracellular Matrix; Fibronectins; Gene Expression; Glomerulonephritis, Membranous; Hypoglycemic Agents; Isoantibodies; Kidney Cortex; Kidney Glomerulus; Male; Membrane Proteins; Plasminogen Activator Inhibitor 1; PPAR gamma; Proteinuria; Rats; Rats, Inbred BN; Rosiglitazone; Stem Cells; Thiazolidinediones; Transforming Growth Factor beta; Urea | 2008 |
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.
Topics: Animals; Apolipoproteins E; Becaplermin; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoglycemic Agents; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-sis; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta | 2008 |
Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Immunohistochemistry; Interleukin-10; Interleukin-4; Interleukin-6; Kidney; Male; Nitric Oxide; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta; Ureteral Obstruction | 2009 |
Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
Topics: Acetylation; Actins; Base Sequence; Cell Differentiation; Cells, Cultured; DNA Primers; Fibroblasts; Humans; Ligands; Lung; Oleanolic Acid; p300-CBP Transcription Factors; PPAR gamma; Prostaglandin D2; Pulmonary Fibrosis; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transcription Factor AP-1; Transforming Growth Factor beta | 2009 |
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone.
Topics: Actins; Acute Lung Injury; Age Factors; Animals; Animals, Newborn; beta Catenin; Calcium-Binding Proteins; Calponins; Cells, Cultured; Fibroblasts; Hyperoxia; Hypoglycemic Agents; Lac Operon; Lymphoid Enhancer-Binding Factor 1; Mice; Mice, Transgenic; Microfilament Proteins; PPAR gamma; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta; Wnt Proteins | 2009 |
Development of a rapid culture method to induce adipocyte differentiation of human bone marrow-derived mesenchymal stem cells.
Topics: 1-Methyl-3-isobutylxanthine; Adipocytes; Adipogenesis; Cell Culture Techniques; Culture Media; Dexamethasone; Humans; Insulin; Lipid Metabolism; Mesenchymal Stem Cells; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2010 |
Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Drug Therapy, Combination; gamma-Globulins; Glomerulonephritis, IGA; Intercellular Adhesion Molecule-1; Kidney; Leukocytes, Mononuclear; Losartan; Mesangial Cells; Nephrectomy; PPAR gamma; Proteinuria; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
Differential effects of advanced glycation end-products on renal tubular cell inflammation.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Chemokine CCL2; Connective Tissue Growth Factor; Epithelial Cells; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-6; Kidney Tubules, Proximal; Lysine; Nephritis, Interstitial; NF-kappa B; Pyruvaldehyde; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Serum Albumin; Serum Albumin, Bovine; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
[PPARγ up-regulates TGFβ/smad signal pathway repressor c-Ski].
Topics: Anilides; Animals; Atherosclerosis; Cells, Cultured; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Proto-Oncogene Proteins; Rats; Rats, Wistar; Repressor Proteins; RNA, Messenger; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Up-Regulation | 2011 |
Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.
Topics: Cell Adhesion; Cells, Cultured; Fibroblasts; Fibrosis; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hypoglycemic Agents; Inflammation; Ligands; Orbit; Orbital Diseases; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
Topics: Airway Remodeling; Animals; Animals, Newborn; Antibodies, Neutralizing; Chronic Disease; Collagen; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice; Mice, Inbred C57BL; PPAR gamma; Pulmonary Alveoli; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Base Sequence; Cell Line; Connective Tissue Growth Factor; DNA Primers; Estradiol; Female; Gene Expression; Humans; Male; Mesenchymal Stem Cells; Mice; Multipotent Stem Cells; Osteoblasts; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2012 |
The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats.
Topics: Animals; Connective Tissue Growth Factor; Female; Fibrosis; Hypoglycemic Agents; Ovary; Polycystic Ovary Syndrome; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2012 |
Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.
Topics: Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glioma; Humans; Phosphorylation; Rosiglitazone; Smad3 Protein; Thiazolidinediones; Transforming Growth Factor beta | 2012 |
Topical rosiglitazone is an effective anti-scarring agent in the cornea.
Topics: Actins; Administration, Topical; Animals; Cats; Cell Differentiation; Cells, Cultured; Cicatrix; Cornea; Corneal Wavefront Aberration; Drug Evaluation, Preclinical; Myofibroblasts; PPAR gamma; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta; Treatment Outcome; Wound Healing | 2013 |
Enamel matrix derivative inhibits adipocyte differentiation of 3T3-L1 cells via activation of TGF-βRI kinase activity.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Benzamides; Cell Differentiation; Connective Tissue Growth Factor; Dental Enamel Proteins; Dioxoles; Gene Expression Regulation; Hot Temperature; Indomethacin; Mice; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2013 |
Novel effects of rosiglitazone on SMAD2 and SMAD3 signaling in white adipose tissue of diabetic rats.
Topics: Adipose Tissue, White; Animals; Diabetes Mellitus, Experimental; Male; PPAR gamma; Protein Serine-Threonine Kinases; Rats; Rats, Zucker; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Rosiglitazone; Signal Transduction; Smad2 Protein; Smad3 Protein; Thiazolidinediones; Transforming Growth Factor beta | 2014 |
Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.
Topics: Animals; Cells, Cultured; Collagen; Mice; Phosphorylation; Pioglitazone; Podocytes; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Smad2 Protein; Smad3 Protein; Thiazolidinediones; Transforming Growth Factor beta; Up-Regulation | 2015 |
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transdifferentiation; Epithelial-Mesenchymal Transition; Female; Flavonoids; Humans; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Proto-Oncogene Proteins c-met; Rosiglitazone; Signal Transduction; Transforming Growth Factor beta | 2019 |
Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Graft Rejection; Humans; Kidney; Kidney Transplantation; Macrophages; Male; PPAR gamma; Rats; Rats, Inbred Lew; Rosiglitazone; Signal Transduction; Transforming Growth Factor beta | 2019 |
Adipocytes fail to maintain cellular identity during obesity due to reduced PPARγ activity and elevated TGFβ-SMAD signaling.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Animals; Cell Differentiation; Diet, High-Fat; Humans; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; PPAR gamma; Rosiglitazone; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2020 |
PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
Topics: Animals; Cell Proliferation; Creatinine; Dialysis Solutions; Glucose; Glucose Transporter Type 1; Nitrogen; Peritoneal Fibrosis; PPAR gamma; Prostaglandin D2; Rats; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta; Urea | 2022 |